glp-1 ozempic diabetes drugs like may modestly reduce cancer risks Five Unexpected New Uses for

& Thieu, V

Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E

In line with our short-term metabolic analyses, previous studies in New Zealand obese and diet-induced obese male mice suggested that GLP1/E acts primarily at central levels to reverse metabolic alterations by decreasing food intake and body weight, while the potential beneficial effects on pancreatic beta-cells were possibly secondary and indirectly-mediated 33,48

Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease

27-30 GLP-1RAs were also associated with reduced hazard in exudative AMD compared with insulin, aspirin, and statins

By combining semaglutide with cagrilintide (an amylin receptor agonist), this therapy has delivered weight loss results exceeding 20% in clinical trials